Icon Spezial- und allgemeine FachliteraturWissenschaftliche Spezialtitel & allgemeinverständliche Fachliteratur
Icon Versand Europa kostenlosKostenloser, europaweiter Versand
Icon sicher zahlenSichere Bezahlung via Paypal & Überweisung

Pabst Science Publishers Logo

 Ihr Warenkorb
0 Artikel (0,00 €)

Supplement to Therapeutic Plasma Exchange and Selective Plasma Separation Methods

Fundamental Technologies, Pathologies and Clinical Results
Fourth Edition
Bambauer, Rolf; Schiel, Ralf; Straube, Richard; Mavberg, Philipp (Hrsg.)
2026, 144 Seiten
Print:  10,00 € |
PDF: 
978-3-69217-054-1
7,00 € inkl. MwSt.
Menge 
(inkl. MwSt.)
Print nicht verfügbar
PDF: 
978-3-69217-054-1
7,00 € inkl. MwSt.
Menge 
Mehr Informationen
Inhaltsverzeichnis
Autor:Innen
Leseprobe
Presse / Leserstimmen

The Supplement to the Fourth Edition of Therapeutic Plasma Exchange and Selective Plasma Separation Methods provides a new overview of therapeutic apheresis (TA), including semi- and selective methods that are available or will be available in the future. The book discusses new TA techniques, such as CRP adsorption and Inuspheresis alone or with an integrated bioreactor containing an enzyme to deplete L-tryptophan, including their function, indications, criticisms, and prospects. The depletion of L-tryptophan is a new therapy method for all diseases with foreign tissue building. In 3 chapters, methods of semi-selective and selective separation procedures, complications, and side effects of these in different diseases are mentioned.  
Therapeutic apheresis in organ transplantation in renal, liver, heart, lung, and hematopoietic progenitor cell transplantation offers new horizons for patients.  
All mentioned non-selective and selective separation methods are still technically complicated and expensive; therefore, the industry must develop simpler and less costly methods to reduce the tremendously high costs in medicine. Physicians and medical staff must help all patients entrusted to them to the best of their knowledge; that means that medical treatment, and particularly the TA, must be available. In the present time, in which the resources of the health systems decrease enormously, a strong definition of indications for TA is necessary to save the health of our patients and to reduce the high costs in the future. The new version of L-tryptophan depletion with the bioreactor integrated into the inuspheresis system offers new therapeutic possibilities in all diseases of cancer, autoimmune diseases, and dementia.     

Das sagen die anderen:

Icon Spezial- und allgemeine FachliteraturWissenschaftliche Spezialtitel & allgemeinverständliche Fachliteratur
Icon Versand Europa kostenlosKostenloser, europaweiter Versand
Icon sicher zahlenSichere Bezahlung via Paypal & Überweisung